AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
BeyondSpring Inc. Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00F9YLSV3
0.43▼ 0.01 (-3.15%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
0.45
Day's Range
0.42 – 0.45
52-Week Range
0.42 – 2.44
Volume
19.8K
Avg Volume
346.5K
Share Statistics
Shares Outstanding
Employees
44
Exchange
XNAS
Listed
2017-03-09
Share count as of July 31, 2026

BeyondSpring Inc. Ordinary Shares (BYSI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about BeyondSpring Inc. Ordinary Shares (BYSI)
What is BeyondSpring Inc. Ordinary Shares's Market Cap?
BeyondSpring Inc. Ordinary Shares's Market Cap is $17.7M, based on as-reported figures from SEC (XBRL) filings.
What is BeyondSpring Inc. Ordinary Shares's Revenue (TTM)?
BeyondSpring Inc. Ordinary Shares's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is BeyondSpring Inc. Ordinary Shares's Net Income (TTM)?
BeyondSpring Inc. Ordinary Shares's Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.
What is BeyondSpring Inc. Ordinary Shares's EBITDA?
BeyondSpring Inc. Ordinary Shares's EBITDA is -$8.4M, based on as-reported figures from SEC (XBRL) filings.
What is BeyondSpring Inc. Ordinary Shares's Diluted EPS (TTM)?
BeyondSpring Inc. Ordinary Shares's Diluted EPS (TTM) is -0.16, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BYSIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
Revenue
Operating expenses
Research and development
General and administrative
Loss from operations
Foreign exchange gain, net
Interest income
Other income, net
Loss before income tax
Income tax expenses
Net loss from continuing operations
Net loss
Less: Net loss attributable to noncontrolling interests from continuing operations
Less: Net loss attributable to noncontrolling interests from discontinued operations
Net income (loss) attributable to BeyondSpring Inc.
Basic and diluted earnings (loss) per share (in dollars per share)